Nirit Yarom

642 total citations
23 papers, 463 citations indexed

About

Nirit Yarom is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Nirit Yarom has authored 23 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Nirit Yarom's work include Colorectal Cancer Treatments and Studies (7 papers), Gastric Cancer Management and Outcomes (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Nirit Yarom is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Gastric Cancer Management and Outcomes (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Nirit Yarom collaborates with scholars based in Israel, Canada and United States. Nirit Yarom's co-authors include Derek J. Jonker, Avishay Sella, Svetlana Kovel, Amnon Zisman, Jean A. Maroun, Timothy R. Asmis, Michael M. Vickers, Zhong Yao, Manijeh Daneshmand and Glenwood D. Goss and has published in prestigious journals such as Journal of Clinical Oncology, Molecular and Cellular Biology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Nirit Yarom

22 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nirit Yarom Israel 11 269 168 145 118 38 23 463
Zetian Shen China 13 214 0.8× 174 1.0× 109 0.8× 126 1.1× 70 1.8× 30 439
Yuanhe Wang China 12 374 1.4× 311 1.9× 150 1.0× 82 0.7× 39 1.0× 43 576
Beverly Spicer United States 3 226 0.8× 113 0.7× 126 0.9× 118 1.0× 39 1.0× 4 435
Jiajia Gu China 13 296 1.1× 188 1.1× 131 0.9× 123 1.0× 31 0.8× 20 435
Shi-Xun Lu China 12 381 1.4× 286 1.7× 142 1.0× 74 0.6× 50 1.3× 12 572
Duk‐Hwan Kim South Korea 10 349 1.3× 136 0.8× 109 0.8× 59 0.5× 44 1.2× 10 503
Ping-Li Sun South Korea 13 261 1.0× 128 0.8× 227 1.6× 316 2.7× 49 1.3× 17 531
Hidejiro Torigoe Japan 13 242 0.9× 108 0.6× 216 1.5× 186 1.6× 24 0.6× 28 450
Inés López Spain 10 396 1.5× 258 1.5× 280 1.9× 198 1.7× 35 0.9× 18 664
Jürgen Stahl Australia 10 216 0.8× 75 0.4× 87 0.6× 85 0.7× 35 0.9× 20 364

Countries citing papers authored by Nirit Yarom

Since Specialization
Citations

This map shows the geographic impact of Nirit Yarom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nirit Yarom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nirit Yarom more than expected).

Fields of papers citing papers by Nirit Yarom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nirit Yarom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nirit Yarom. The network helps show where Nirit Yarom may publish in the future.

Co-authorship network of co-authors of Nirit Yarom

This figure shows the co-authorship network connecting the top 25 collaborators of Nirit Yarom. A scholar is included among the top collaborators of Nirit Yarom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nirit Yarom. Nirit Yarom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hubert, Ayala, Sofia Man, Ravit Geva, et al.. (2024). Treatments and clinical outcomes in stage II colon cancer patients with 12-gene Oncotype DX Colon Recurrence Score® assay-guided therapy: real-world data. ESMO Open. 9(8). 103648–103648. 1 indexed citations
2.
Brenner, Baruch, Ayala Hubert, Sofia Man, et al.. (2023). Treatments and clinical outcomes in stage II colon cancer (CC) patients (pts) with 12-gene Oncotype DX Colon Recurrence Score assay-guided therapy: Real-world data.. Journal of Clinical Oncology. 41(16_suppl). 3620–3620.
3.
Shacham‐Shmueli, Einat, Ofir Morag, Ofer Margalit, et al.. (2022). Single-Fraction Celiac Plexus Radiosurgery: A Preliminary Proof-of-Concept Phase 2 Clinical Trial. International Journal of Radiation Oncology*Biology*Physics. 113(3). 588–593. 10 indexed citations
4.
Varghese, Anna M., Celina Ang, Christopher J. DiMaio, et al.. (2020). A phase II study of siG12D-LODER in combination with chemotherapy in patients with locally advanced pancreatic cancer (PROTACT).. Journal of Clinical Oncology. 38(15_suppl). TPS4672–TPS4672. 36 indexed citations
6.
Yarom, Nirit, et al.. (2015). Colon cancer in immigrants from Ethiopia.. Journal of Clinical Oncology. 33(3_suppl). 521–521. 1 indexed citations
7.
Lavy, Ron, et al.. (2015). D1 versus D2 Gastrectomy for Gastric Adenocarcinoma.. PubMed. 17(12). 735–8. 3 indexed citations
8.
Lavy, Ron, et al.. (2014). A comparative study on two different pathological methods to retrieve lymph nodes following gastrectomy. International Journal of Surgery. 12(7). 725–728. 10 indexed citations
9.
Yarom, Nirit, et al.. (2013). Phase I Clinical Trial of Exherin (ADH-1) in Patients with Advanced Solid Tumors. Current Clinical Pharmacology. 8(1). 81–88. 13 indexed citations
10.
Yarom, Nirit, et al.. (2013). Phase I Clinical Trial of Exherin (ADH-1) in Patients with Advanced Solid Tumors. Current Clinical Pharmacology. 8(1). 81–88. 23 indexed citations
11.
Vickers, Michael M., Jair Bar, Nirit Yarom, et al.. (2011). Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease. Clinical & Experimental Metastasis. 29(2). 123–132. 99 indexed citations
12.
Yarom, Nirit, et al.. (2011). ADH-1 in the treatment of metastatic adrenocortical carcinoma--case report.. PubMed. 31(11). 3921–5. 7 indexed citations
13.
Yarom, Nirit & Derek J. Jonker. (2011). The role of the epidermal growth factor receptor in the mechanism and treatment of colorectal cancer.. PubMed. 11(57). 95–105. 85 indexed citations
14.
Avraham, Ayelet, Judith Sandbank, Nirit Yarom, et al.. (2010). A similar cell-specific pattern of HOXA methylation in normal and in cancer tissues. Epigenetics. 5(1). 41–46. 13 indexed citations
15.
Yarom, Nirit, Celia Marginean, Terence Moyana, et al.. (2010). EGFR expression variance in paired colorectal cancer primary and metastatic tumors. Cancer Biology & Therapy. 10(5). 416–421. 18 indexed citations
16.
Yarom, Nirit, et al.. (2009). Epistaxis during Treatment with Paclitaxel. Basic & Clinical Pharmacology & Toxicology. 104(3). 259–261. 1 indexed citations
17.
Sella, Avishay, Nirit Yarom, Amnon Zisman, & Svetlana Kovel. (2009). Paclitaxel, Estramustine and Carboplatin Combination Chemotherapy after Initial Docetaxel-Based Chemotherapy in Castration-Resistant Prostate Cancer. Oncology. 76(6). 442–446. 26 indexed citations
18.
Sella, Avishay, et al.. (2008). Neoadjuvant Chemohormonal Therapy in Poor-Prognosis Localized Prostate Cancer. Urology. 71(2). 323–327. 27 indexed citations
19.
Sella, Avishay, Cora N. Sternberg, Svetlana Kovel, Nirit Yarom, & Iwona Skoneczna. (2007). Progression after docetaxel‐based chemotherapy in androgen‐independent prostate cancer. British Journal of Urology. 100(3). 533–535. 3 indexed citations
20.
Aebersold, Daniel M., Yoav D. Shaul, Yuval Yung, et al.. (2004). Extracellular Signal-Regulated Kinase 1c (ERK1c), a Novel 42-Kilodalton ERK, Demonstrates Unique Modes of Regulation, Localization, and Function. Molecular and Cellular Biology. 24(22). 10000–10015. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026